ketotifen has been researched along with Mastocytosis, Systemic in 2 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
Mastocytosis, Systemic: A group of disorders caused by the abnormal proliferation of MAST CELLS in a variety of extracutaneous tissues including bone marrow, liver, spleen, lymph nodes, and gastrointestinal tract. Systemic mastocytosis is commonly seen in adults. These diseases are categorized on the basis of clinical features, pathologic findings, and prognosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Molderings, GJ | 1 |
| Homann, J | 1 |
| Brettner, S | 1 |
| Raithel, M | 1 |
| Frieling, T | 1 |
| Klepper, L | 1 |
| Tronnier, M | 1 |
1 review available for ketotifen and Mastocytosis, Systemic
| Article | Year |
|---|---|
[Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options].
Topics: Adult; Algorithms; Ascorbic Acid; Bone Marrow; Child; Combined Modality Therapy; Diagnosis, Differen | 2014 |
1 other study available for ketotifen and Mastocytosis, Systemic
| Article | Year |
|---|---|
[Multiple fibromas in systemic mastocytosis].
Topics: Aged; Antidepressive Agents, Tricyclic; Antipruritics; Biopsy; Fibroma; Histocytochemistry; Humans; | 2005 |